Contact this trialFirst, we need to learn more about you.
Nonsteroidal Anti-inflammatory Drug
Aspirin for Pre-eclampsia Prevention
Recruiting3 awardsPhase 4
Charlottesville, Virginia
This trial will compare the effects of taking either 81 mg/day or 162 mg/day of aspirin on pregnant women at high risk of developing preeclampsia. The study aims to see
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service